NICM
CC icon

Neo Ivy Capital Management’s Chemours CC Stock Holding History

Neo Ivy Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-93,260
Closed -$1.48M – 367
2025
Q3 		$1.48M Buy
+93,260
New +$1.35M 0.36% 103
2025
Q1 		– Sell
-57
Closed – – 301
2024
Q4 		$0 Buy
+57
New +$1.11K ﹤0.01% 288
2023
Q4 		$40K Buy
+1,264
New +$34.3K 0.09% 186
2022
Q4 		– Sell
-6,700
Closed -$165K – 357
2022
Q3 		$165K Buy
+6,700
New +$221K 0.43% 78
2021
Q1 		– Sell
-1,535
Closed -$38K – 487
2020
Q4 		$38K Buy
+1,535
New +$36.5K 0.04% 329

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Neo Ivy Capital Management's CC Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Chemours (CC) in Q4 2025, closing a stake of 93,260 shares — an estimated $1.48M sold.

Neo Ivy Capital Management first reported a position in CC in Q4 2020 and held it in 5 quarters. The position peaked at $1.48M in Q3 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 93,260 Chemours shares in Q4 2025, an estimated $1.48M.
  • Neo Ivy Capital Management first reported a position in Chemours in Q4 2020 and held it in 5 quarters.
  • Neo Ivy Capital Management's Chemours position peaked at $1.48M in Q3 2025.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.